Biparametric MRI for Detection of Significant Prostate Cancer

NACompletedINTERVENTIONAL

Enrollment

1,063

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

December 1, 2018

Conditions

Prostate Cancer

Interventions

DEVICE

Biparametric MRI before biopsy

All included men with suspicious lesions on bpMRI will have bpMRI targeted biopsies in addition to standard TRUS-bx.

Trial Locations (1)

Herlev Hospital, Herlev

All Listed Sponsors

lead

Herlev Hospital

OTHER

NCT02584179 - Biparametric MRI for Detection of Significant Prostate Cancer | Biotech Hunter | Biotech Hunter